|One of the sharpest declines among software stocks has been Alteryx (AYX). On July 9th - just 25-trading days ago - it hit a high of $185.75. It is currently trading at $108.22 . . . down almost 42%. A sharp decline like that triggered a search of my research files and I came up with the following, and excerpt of an interview between Tiernan Ray and Kevin Rubin, CFO of AYX:|
Kevin “Data doesn’t go away. Questions around the business don’t go away. And so some of the conversation may shift from certain types of use cases in the areas of impact to more ROI and efficiency-driven discussions.
But the applicability of Alteryx in down times is probably even more, even stronger than in robust states.
And again it goes back to companies that had only been dabbling with digital transformation or data initiatives are going to find themselves in a really difficult spot as they go through whatever this recovery looks like without being able to leverage data for decision making.
Because I can tell you their competitors are. And so when you think about a competitive advantage if you’re not leveraging everything available to you to make decisions, you’re going to struggle.
I was just going to mention we have very, very low penetration, still, in what is a ginormous addressable market. Plus or minus 50 million citizen data scientists out there that we believe Alteryx addresses. We have less than 1 percent penetration today.”